Universe Pharmaceuticals INC F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Universe Pharmaceuticals is launching a best efforts self-underwritten public offering of up to 20,000,000 ordinary shares at $1.25 per share to raise capital amid risks associated with operating in China and regulatory uncertainties.
NASDAQ
Universe Pharmaceuticals is launching a best efforts self-underwritten public offering of up to 20,000,000 ordinary shares at $1.25 per share to raise capital for expansion and general corporate purposes.